Frequency of progression to undergo HCT and reasons documented for failure to proceed to undergo HCT among the subgroup of patients treated based on race
| . | Black (N = 67) . | White (N = 174) . | P value . |
|---|---|---|---|
| Number of patients proceeding to undergo HCT | 32 (48%) | 102 (59%) | .13 |
| Reasons for failure to proceed to HCT | (N = 35) | (N = 72) | |
| Comorbidities | 11 (31%) | 28 (39%) | .45 |
| KPS | 6 (17%) | 14 (19%) | .77 |
| Caregiver issues | 13 (37%) | 8 (11%) | .002 |
| Refractory disease | 6 (17%) | 15 (21%) | .65 |
| Patient declined | 5 (14%) | 13 (18%) | .62 |
| Induction death | 6 (17%) | 4 (6%) | .05 |
| . | Black (N = 67) . | White (N = 174) . | P value . |
|---|---|---|---|
| Number of patients proceeding to undergo HCT | 32 (48%) | 102 (59%) | .13 |
| Reasons for failure to proceed to HCT | (N = 35) | (N = 72) | |
| Comorbidities | 11 (31%) | 28 (39%) | .45 |
| KPS | 6 (17%) | 14 (19%) | .77 |
| Caregiver issues | 13 (37%) | 8 (11%) | .002 |
| Refractory disease | 6 (17%) | 15 (21%) | .65 |
| Patient declined | 5 (14%) | 13 (18%) | .62 |
| Induction death | 6 (17%) | 4 (6%) | .05 |